Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

NCT06350825 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer
Therapy, Directly Observed

Interventions

PROCEDURE: Cytoreductive prostatectomy or brachytherapy
DRUG: ADT+second-generation antiandrogens ± chemotherapy

Sponsor

The First Affiliated Hospital with Nanjing Medical University